With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities||Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD||'A' Award Grants||2019||Massachusetts|
|Single-cell Atlas of Pediatric Osteosarcoma||Dana-Farber Cancer Institute / Natalie Collins, MD/PhD||Single-cell Pediatric Cancer Atlas Grant||2019||Massachusetts|
|Targeted Hyperactivation of PI3K/AKT in B-cell malignancies||Dana-Farber Cancer Institute / Vishal Khairnar, PhD||Young Investigator Grants||2019||Massachusetts|
|Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis||Duke University / Corinne Linardic, MD/PhD||Innovation Grants||2019||North Carolina|
|The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma||Emory University / Anna Kenney, PhD||Innovation Grants||2019||Georgia|
|Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies||Emory University / Christopher Porter, MD||Innovation Grants||2019||Georgia|
|Characterization of Chromatin Landscapes to Identify Therapeutic Vulnerabilities in Diffuse Midline Gliomas.||Fred Hutchinson Cancer Research Center / Jay Sarthy, MD/PhD||Young Investigator Grants||2019||Washington|
|Targeting a Novel Epigenetic Signature in Diffuse Intrinsic Pontine Gliomas||New York University School of Medicine / Danny Reinberg, PhD||Reach Grants||2019||New York|
|Targeting Valine-Specific Amino Acid Dependency -in T-Cell Acute Lymphoblastic Leukemia||New York University School of Medicine / Palaniraja Thandapani, PhD||Young Investigator Grants||2019||New York|
|Developing drugs to treat NT5C2 mediated resistance in pediatric ALL||New York University School of Medicine / William Carroll, MD||Innovation Grants||2019||New York|